Secreted wnt antagonists during eradication of cytomegalovirus infection in solid organ transplant recipients

American Journal of Transplantation

Volumn 14, Issue 1, 2014, Pages 210-215

  Ueland, T ^a,b   Rollag, H ^a,b   Hartmann, A ^b,c   Jardine, A G ^d   Humar, A ^e   Michelsen, A E ^a   Bignamini, A A ^f   Asberg A ^g   Aukrust, P ^a,c  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d UNIVERSITY OF GLASGOW   (United Kingdom)

^e UNIVERSITY OF ALBERTA   (Canada)

^f UNIVERSITY OF MILAN   (Italy)

^g UNIVERSITY OF OSLO   (Norway)

Author keywords

CMV infection; solid organ transplant recipients; virological outcome; Wnt signaling

Indexed keywords

C REACTIVE PROTEIN; DICKKOPF 1 PROTEIN; GANCICLOVIR; SECRETED FRIZZLED RELATED PROTEIN 3; UNCLASSIFIED DRUG; VALGANCICLOVIR; WNT1 PROTEIN;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; CONCURRENT INFECTION; CYTOMEGALOVIRUS INFECTION; DRUG TREATMENT FAILURE; EPSTEIN BARR VIRUS INFECTION; FEMALE; FOLLOW UP; GRAFT RECIPIENT; HUMAN; LIMIT OF QUANTITATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; POST HOC ANALYSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SIGNAL TRANSDUCTION; SOLID ORGAN TRANSPLANT RECIPIENT; TREATMENT OUTCOME; VIRAL CLEARANCE; VIRUS REPLICATION;

CMV INFECTION; SOLID ORGAN TRANSPLANT RECIPIENTS; VIROLOGICAL OUTCOME; WNT SIGNALING;

ADULT; CYTOMEGALOVIRUS INFECTIONS; DNA, VIRAL; FEMALE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; ORGAN TRANSPLANTATION; PROTEINS; WNT SIGNALING PATHWAY;

EID: 84891039307     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.12506     Document Type: Article

References (13)

1. Snydman DR., The case for cytomegalovirus prophylaxis in solid organ transplantation. Rev Med Virol 2006; 16: 289-295.
2. Noriega V, Redmann V, Gardner T, Tortorella D., Diverse immune evasion strategies by human cytomegalovirus. Immunol Res 2012; 54: 140-151.
3. Evers DL, Wang X, Huang ES., Cellular stress and signal transduction responses to human cytomegalovirus infection. Microbes Infect 2004; 6: 1084-1093.
4. Hayward SD, Liu J, Fujimuro M., Notch and Wnt signaling: Mimicry and manipulation by gamma herpesviruses. Sci STKE 2006; 2006: re4.
5. Clevers H, Nusse R., Wnt/beta-catenin signaling and disease. Cell 2012; 149: 1192-1205.
6. Angelova M, Zwezdaryk K, Ferris M, Shan B, Morris CA, Sullivan DE., Human cytomegalovirus infection dysregulates the canonical Wnt/beta-catenin signaling pathway. PLoS Pathog 2012; 8: e1002959.
7. Asberg A, Humar A, Rollag H, et al. Oral valganciclovir is noninferior to intravenous ganciclovir for the treatment of cytomegalovirus disease in solid organ transplant recipients. Am J Transplant 2007; 7: 2106-2113.
8. DeLong ER, DeLong DM, Clarke-Pearson DL., Comparing the areas under two or more correlated receiver operating characteristic curves: A nonparametric approach. Biometrics 1988; 44: 837-845.
9. Robin X, Turck N, Hainard A, et al. pROC: An open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics 2011; 12: 77.
10. Stevenson M, Nunes T, Sanchez J, Thornton R., epiR: Functions for analysing epidemiological data. R package version 0.9-32, 2011. Available at: http://CRANR-project org/package=epiR 2011. Accessed February 6, 2013.
11. R Development Core Team. A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing, 2010. ISBN: 3-900051-07-0. Available at: http://www.R-project org/2010. Accessed February 6, 2013.
12. Asberg A, Jardine AG, Bignamini AA, et al. Effects of the intensity of immunosuppressive therapy on outcome of treatment for CMV disease in organ transplant recipients. Am J Transplant 2010; 10: 1881-1888.
13. Kumar A, Zloza A, Moon RT, Watts J, Tenorio AR, Al-Harthi L., Active beta-catenin signaling is an inhibitory pathway for human immunodeficiency virus replication in peripheral blood mononuclear cells. J Virol 2008; 82: 2813-2820.